跳至主要内容
临床试验/CTRI/2021/05/033724
CTRI/2021/05/033724已完成未知

Role of Maternal serum placental growth factor and hematological parameters at 11â??14weeks of gestation to predict gestational diabetes mellitus: A Prospective observational study

Dr Mounika Koduri0 个研究点目标入组 320 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
320

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Inclusion Criteria: Singleton pregnancies at 11-14 weeks of gestation, at the time of combined
  • screening for aneuploidy and preeclampsia by ultrasound scan and maternal serum
  • biochemistry, who come to obstetrics and gynaecology OPD of Kasturba Hospital Manipal for
  • regular ANC checkup.

排除标准

  • Exclusion Criteria:
  • 1)Women who have been diagnosed with hypertensive disorders in pregnancy
  • 2)Previous pregnancy complicated with Gestational diabetes mellitus (GDM)
  • 3)Pre-existing diabetes mellitus detected by HbA1C >6
  • 4)Pregnancies with chromosomal abnormal fetuses or structural defects at 11-14 weeks
  • 5)Pregnancies diagnosed with severe Early onset IUGR
  • 6)Those who are not willing to participate in the study.

研究者

发起方
Dr Mounika Koduri

相似试验

Placental growth factor and haeme indicesto predict... | 临床试验